Dr. Bauer’s research interests include cancer genomics and integration of heterogenous datasets in multiple myeloma and investigating cancer disparities in minority and rural populations.
Brian Koss, Ph.D.
Dr. Koss’s research interests are focused on understanding the fundamental mechanisms T cells utilize to adapt to environmental stress. His laboratory is currently developing and applying cutting-edge proteomic approaches to elucidate how proteome turnover dynamics influence the ability of a T cell to persist in solid tumors. To translate these findings, his laboratory seeks to […]
Mohammad A. Rahman, Ph.D.
Dr. Rahman’s laboratory is interested to study the mechanisms of alternative splicing (AS) and nonsense-mediated mRNA decay (NMD) misregulation in cancer, and the means by which faulty AS or/and NMD can be corrected for therapy. My research utilizes biochemistry, molecular biology, genome editing, transcriptomics, proteomics, computational biology, and antisense pharmacology to study RNA metabolism in normal and cancer cells to contribute in developing […]
Katie Ryan, Ph.D.
Sean Taverna, Ph.D.
The Taverna laboratory studies how histone marks contribute to an “epigenetic/histone code” that may dictate chromatin-templated functions like transcriptional activation and gene silencing, as well as how these On/Off states are inherited/ propagated. For example, transcription-modulating protein complexes with PHD finger motifs (methyl lysine “readers”) or Bromodomains (acetyl lysine “readers”) often have enzymatic activities that […]
Adam Wolfe, M.D., Ph.D.
Dr. Wolfe’s research is interdisciplinary, spanning the interface between DNA repair and radiation therapy in deadly cancers. The lab studies aspects of oncogenic DNA repair regulation, homologous recombination dynamics, and radiation mouse models of human cancer.
Yong Zhu, Ph.D., M.S., M.A.
Dr. Zhu’s research interests focus on identifying biomarkers associated with cancer risk, progression, and survival, as well as investigating their translational implications. His laboratory examines the impact of circadian factors, such as night shift work and changes in circadian genes, on tumorigenesis. Another focus involves translational research into small noncoding RNAs.
Ngai Chung Neville Tam, Ph.D.
My primary research interest is to understand how endocrine status, diet and environment contribute to urological diseases encompassing prostate cancer, benign prostatic hyperplasia and lower urinary tract dysfunctions, with a focus on the role of physiological / dietary / environmental estrogens in uropathology. The knowledge gained from our research will foster development of better strategies […]
Jeffery H. Moran, Ph.D.
My passion for applying new analytical techniques to enhance our knowledge of toxicological mechanisms was evident early in my career. I began my toxicological training as an undergraduate in 1994 and published my first article in 1996, which reported a new analytical technique to detect cell death. Since this date, my career has focused on […]
Michael Berquist II, Ph.D.
Dr. Michael Berquist’s research goal is to prevent the development of alcohol use disorder in individuals with stress exposure, including exposure to early life adversity and prenatal opioid exposure. Our group is currently interested in the use of psychedelics, including novel lysergamides, to thwart alcohol drinking and preference. Dr. Berquist primarily uses behavioral assays in […]